← back to search

Andrea Evangelista

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino ·
Area of research
Pathology and Forensic Medicine · Hematology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, and Viral-associated cancers and disorders.
h-index
45
citations
9,235
works
290
NIH funding
primary concept
email

Recent publications

Age-related remodeling of the sialoglycans dampens murine CD8 <sup>+</sup> T cell function
Science Advances 2025cited by 2position: middledoi
Post-transplant lymphoproliferative disorders in adult transplant recipients: Preliminary results of the multicenter italian FIL_PTLD study
Blood 2025cited by 0position: middledoi
Impact of different follow-up regimens on health-related quality of life and costs in endometrial cancer patients: Results from the TOTEM randomized trial
Gynecologic Oncology 2024cited by 3position: middledoi
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL
Blood Advances 2023cited by 23position: middledoi
Macroscopic Synovial Inflammation Correlates with Symptoms and Cartilage Lesions in Patients Undergoing Arthroscopic Partial Meniscectomy: A Clinical Study
Journal of Clinical Medicine 2022cited by 35position: middledoi
Effectiveness of a multi-layer silicone-adhesive polyurethane foam dressing as prevention for sacral pressure ulcers in at-risk in-patients: Randomized controlled trial
International Journal of Nursing Studies 2022cited by 30position: middledoi
Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation
Bone Marrow Transplantation 2020cited by 44position: middledoi
Time to progression of mantle cell lymphoma after high‐dose cytarabine‐based regimens defines patients risk for death
British Journal of Haematology 2018cited by 70position: middledoi
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis
Critical Reviews in Oncology/Hematology 2018cited by 31position: middledoi
Rituximab maintenance improves overall survival of patients with follicular lymphoma—Individual patient data meta-analysis
European Journal of Cancer 2017cited by 60position: middledoi
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi
The Lancet Haematology 2016cited by 138position: middledoi
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
Blood 2015cited by 757position: middledoi
Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database
European Journal of Cardio-Thoracic Surgery 2014cited by 241position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Benedetto Bruno · Department of Public Health1 papers (2020–2020)Elisa Piovano · University of Turin1 papers (2024–2024)Michele Ghielmini · Institute of Oncology Research1 papers (2017–2017) · 1 papers (2024–2024) · 1 papers (2024–2024)Riddhi Modi · University of Alabama at Birmingham1 papers (2020–2020) · 1 papers (2017–2017)Stefan Schönland · University of Pennsylvania1 papers (2020–2020)Catherine Fortpied · National Cancer Institute1 papers (2017–2017)Ruth Pettengell · St George's Hospital1 papers (2017–2017) · 1 papers (2025–2025)Roberta Ramonda · University of Padua1 papers (2022–2022) · 1 papers (2024–2024) · 1 papers (2024–2024)Assunta Pozzuoli · University of Padua1 papers (2022–2022)Esther Jeong Yoon Kim · University of California, Berkeley1 papers (2025–2025)Francesca Patriarca · University of Udine1 papers (2020–2020)Ofer Shpilberg · Assuta Medical Center1 papers (2017–2017)Anat Gafter‐Gvili · Tel Aviv University1 papers (2017–2017)C. Kimberly Tsui · Howard Hughes Medical Institute1 papers (2025–2025)